2003
Cystatin C as a cerebrospinal fluid biomarker for pain in humans
Mannes A, Martin B, Yang H, Keller J, Lewin S, Gaiser R, Iadarola M. Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain 2003, 102: 251-256. PMID: 12670666, DOI: 10.1016/s0304-3959(02)00403-7.Peer-Reviewed Original ResearchConceptsCerebrospinal fluidCystatin CMcGill Short Form QuestionnaireCystatin C increaseNon-pain patientsElective caesarean sectionBeta-endorphin contentDorsal spinal cordVisual analog scaleCerebrospinal fluid biomarkersTotal CSF proteinPrevious animal studiesShort-form questionnairePeripheral inflammationCaesarean sectionSevere painDorsal hornPain statesPersistent painPain patientsAnalog scaleObstetrical patientsFluid biomarkersControl subjectsSpinal cord
1997
Comparison of 0.25% ropivacaine and bupivacaine for epidural analgesia for labor and vaginal delivery
Gaiser R, Venkateswaren P, Cheek T, Persiley E, Buxbaum J, Hedge J, Joyce T, Gutsche B. Comparison of 0.25% ropivacaine and bupivacaine for epidural analgesia for labor and vaginal delivery. Journal Of Clinical Anesthesia 1997, 9: 564-568. PMID: 9347433, DOI: 10.1016/s0952-8180(97)00145-1.Peer-Reviewed Original ResearchConceptsASA physical status IPhysical status IVisual analog scaleMotor blockadeApgar scoreStatus IActive laborSensory levelContinuous lumbar epidural infusionUmbilical cord blood samplesLumbar epidural infusionMaternal blood pressureUmbilical cord gasesLumbar epidural catheterDouble-blind studyCord blood samplesMajor adverse effectsMaternal arterial concentrationsNon-blind studyAdaptive capacity scoresContraction painNeonatal effectsRopivacaine groupRopivacaine levelsBupivacaine group